Research

Cellular

Adverse events from semaglutide were generally mild to moderate gastrointestinal effects and occurred more frequently in the semaglutide group.

Clinicians should monitor for mild to moderate gastrointestinal side effects in patients treated with semaglutide.

StrongQualifiesmedium confidence
Adverse events were transient, generally mild to moderate gastrointestinal effects, and occurred more frequently in the semaglutide group.
Mette Kruse Klausen et al. · The Lancet · 2026

Why this rating

Based on the randomized, double-blind, placebo-controlled trial design.

Source

Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial

Mette Kruse Klausen et al. · The Lancet · 2026

DOI 10.1016/s0140-6736(26)00305-3

rct · n=108Cited 4×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →